---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-000990"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2021-08-04T23:59:59+00:00"
generated_at: "2026-06-29T22:20:32.817451+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Charles River Q2 revenue $914.6M (+34% YoY); raises 2021 guidance above prior estimates

## Summary
- Revenue $914.6M, +34% YoY (organic +24.1%); GAAP EPS $1.72, non-GAAP EPS $2.61.
- Non-GAAP EPS of $2.61 beat prior year $1.58; net income $88.4M GAAP, $133.8M non-GAAP.
- All three segments drove organic growth: RMS +44.5%, DSA +18.1%, Manufacturing +26.6%.
- 2021 guidance raised: revenue growth 20.5-22.5% (was 19-21%), non-GAAP EPS $10.10-$10.35 (was $9.75-$10.00), FCF ~$500M.
- CEO cites robust client demand and strengthened portfolio; company adding staff and capacity.

## SEC filing metadata
- accession: 0001157523-21-000990
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2021-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000115752321000990/0001157523-21-000990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000115752321000990/a52470970.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-000990
- JSON: https://secwatch.observer/filing/0001157523-21-000990.json
- Plain text: https://secwatch.observer/filing/0001157523-21-000990.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.